Article
Multi-compartment immune and tumor cell reprogramming by IFNα2 overcomes colon cancer immunotherapy resistance
2026-07-01
Abstract excerpt
<h4>SUMMARY</h4> Tumor cell PD-L1 represses IFN signaling to limit anti-tumor immunity, despite an IFN-responsive immunophenotype predicting colorectal cancer response to immune checkpoint inhibitor therapy. Lipid nanoparticle (LNP)-encapsulated IFNα2-encoding nanoplasmid (LNP-mIFNα2) gene therapy suppresses tumor progression, however, the underlying mechanism and therapeutic trade-offs of the accompanying proinf...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- dc9b9852-8a1a-526f-b991-1f46efc18e75
- DOI
- 10.64898/2026.06.26.734809
